ENDONOVO THERAPEUTICS, INC. Proceeds from Issuance of Common Limited Partners Units
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Proceeds from Issuance of Common Limited Partners Units of $100.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-19.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonLimitedPartnersUnits · last filed 2020-11-19
- ENDONOVO THERAPEUTICS, INC. proceeds from issuance of common limited partners units for the quarter ending 2019-09-30 was $10.00K.
- ENDONOVO THERAPEUTICS, INC. proceeds from issuance of common limited partners units for the quarter ending 2019-06-30 was $33.55K.
- ENDONOVO THERAPEUTICS, INC. proceeds from issuance of common limited partners units for the quarter ending 2019-03-31 was $27.56K.
| Period end | Proceeds from Issuance of Common Limited Partners Units 3 month | Proceeds from Issuance of Common Limited Partners Units 6 month | Proceeds from Issuance of Common Limited Partners Units 9 month |
|---|---|---|---|
| 2020-09-30 | $100.00K 10-Q · filed 2020-11-19 | ||
| 2019-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-19 | $43.55K derived: sum of 2 quarters · filed 2020-11-19 | $71.11K 10-Q · filed 2020-11-19 |
| 2019-06-30 | $33.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-19 | $61.11K 10-Q · filed 2020-08-19 | |
| 2019-03-31 | $27.56K 10-Q · filed 2020-06-12 |